EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 3.0

Superior Efficacy and Deep Molecular Remission with Venetoclax Plus Hypomethylating Agent in Elderly Acute Myeloid Leukemia: A Real-World Comparative Cohort Study

Chen Luo, Yuhan Jiang, Huiling Yan, Kan Sun, Wentao Li, Mengqing Cao, Lijun Zhu, Xing Hu, Juan Tong iD, Changcheng Zheng iD

Clinical Pharmacology: Advances and Applications · 2026-05 · Volume 18 · 1-10

DOI: 10.2147/cpaa.s596901 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Pharmacology: Advances and Applications, 2026-05. Verfasst von Chen Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Graduate School of WanNan Medical College, Wuhu, People's Republic of China. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

hypomethylating agentlow-intensity induction chemotherapymeasurable residual diseaseoverall survivalvenetoclax

Autor:innen und Institutionen

  • Department of Internal Medicine, Graduate School of WanNan Medical College, Wuhu, People's Republic of China.
  • Department of Hematology, Centre for Leading Medicine and Advanced Technologies of IHM, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei…
  • Department of Hematology, Anhui Provincial Hospital, Anhui Medical University, Hefei, People's Republic of China.

ORCID-Profile: Juan Tong, Changcheng Zheng

Zitieren

APA

Luo, C., Jiang, Y., Yan, H., Sun, K., Li, W., Cao, M., Zhu, L., Hu, X., Tong, J., & Zheng, C. (2026). Superior Efficacy and Deep Molecular Remission with Venetoclax Plus Hypomethylating Agent in Elderly Acute Myeloid Leukemia: A Real-World Comparative Cohort Study. Clinical Pharmacology: Advances and Applications, Volume 18, 1-10. https://doi.org/10.2147/cpaa.s596901

Vancouver

Luo C, Jiang Y, Yan H, Sun K, Li W, Cao M, et al. Superior Efficacy and Deep Molecular Remission with Venetoclax Plus Hypomethylating Agent in Elderly Acute Myeloid Leukemia: A Real-World Comparative Cohort Study. Clinical Pharmacology: Advances and Applications. 2026;Volume 18:1-10. doi:10.2147/cpaa.s596901

BibTeX
@article{Luo2026,
  author = {Luo, Chen and Jiang, Yuhan and Yan, Huiling and Sun, Kan and Li, Wentao and Cao, Mengqing and Zhu, Lijun and Hu, Xing and Tong, Juan and Zheng, Changcheng},
  title = {Superior Efficacy and Deep Molecular Remission with Venetoclax Plus Hypomethylating Agent in Elderly Acute Myeloid Leukemia: A Real-World Comparative Cohort Study},
  journal = {Clinical Pharmacology: Advances and Applications},
  year = {2026},
  volume = {Volume 18},
  pages = {1--10},
  doi = {10.2147/cpaa.s596901}
}
Kostenlos starten →